Searchable abstracts of presentations at key conferences in endocrinology

ea0050p057 | Bone and Calcium | SFEBES2017

Imaging in primary hyperparathyroidism; does it affect our referral pathways for surgery? Results of an audit

Dede Anastasia , Morganstein Daniel , Shotliff Kevin , Greener Veronica , Smellie James , Maenhout Annelies , Wren Alison

Introduction: The 4th International Workshop on asymptomatic primary hyperparathyroidism (PHPT) has set criteria for surgical intervention and suggests that a percentage of patients can be managed conservatively. Imaging is indicated only pre-operatively to determine the optimal surgical approach.Patients and methods: We completed an audit on the use of Sestamibi, clinical and biochemical data in patients with PHPT.<...

ea0050p057 | Bone and Calcium | SFEBES2017

Imaging in primary hyperparathyroidism; does it affect our referral pathways for surgery? Results of an audit

Dede Anastasia , Morganstein Daniel , Shotliff Kevin , Greener Veronica , Smellie James , Maenhout Annelies , Wren Alison

Introduction: The 4th International Workshop on asymptomatic primary hyperparathyroidism (PHPT) has set criteria for surgical intervention and suggests that a percentage of patients can be managed conservatively. Imaging is indicated only pre-operatively to determine the optimal surgical approach.Patients and methods: We completed an audit on the use of Sestamibi, clinical and biochemical data in patients with PHPT.<...

ea0094p390 | Thyroid | SFEBES2023

Radioiodine and Graves Orbitopathy (GO): lessons learned from an internal audit of 101 patients

Qin Xian Quah Nicole , Maenhout Annelies , Sobti Manvi , Scawn Richard , Kalogianni Eleni , Cleland James , Wren Alison

GravesÂ’ orbitopathy (GO) development or reactivation is a well-recognised complication of radioactive iodine (RAI), with possible lower incidence in a recent series. We performed a retrospective audit of GravesÂ’ disease patients treated with RAI at our centre over a 5-year period. We recorded the GO incidence after RAI treatment, risk factors present, and steroid prophylaxis use. Data collected: smoking status, thyroid-stimulating hormone receptor antibody (TRAb), GO...